Pulmonary changes at high altitude and altitude sickness


00:00 / 00:00



Pulmonary changes at high altitude and altitude sickness

Respiratory system

Upper respiratory tract disorders

Choanal atresia


Allergic rhinitis

Nasal polyps

Upper respiratory tract infection



Retropharyngeal and peritonsillar abscesses

Bacterial epiglottitis

Nasopharyngeal carcinoma

Lower respiratory tract disorders

Tracheoesophageal fistula

Congenital pulmonary airway malformation

Pulmonary hypoplasia

Neonatal respiratory distress syndrome

Transient tachypnea of the newborn

Meconium aspiration syndrome

Apnea of prematurity

Sudden infant death syndrome

Acute respiratory distress syndrome

Pulmonary changes at high altitude and altitude sickness

Decompression sickness

Cyanide poisoning



Chronic bronchitis


Cystic fibrosis


Alpha 1-antitrypsin deficiency

Restrictive lung diseases


Idiopathic pulmonary fibrosis

Hypersensitivity pneumonitis



Bacterial tracheitis

Lung cancer

Pancoast tumor

Superior vena cava syndrome

Pleura and pleural space disorders


Pleural effusion


Pulmonary vascular disorders

Pulmonary embolism

Pulmonary edema

Pulmonary hypertension

Apnea and hypoventilation

Sleep apnea

Apnea of prematurity

Respiratory system pathology review

Respiratory distress syndrome: Pathology review

Cystic fibrosis: Pathology review

Pneumonia: Pathology review

Tuberculosis: Pathology review

Deep vein thrombosis and pulmonary embolism: Pathology review

Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review

Obstructive lung diseases: Pathology review

Restrictive lung diseases: Pathology review

Apnea, hypoventilation and pulmonary hypertension: Pathology review

Lung cancer and mesothelioma: Pathology review


Pulmonary changes at high altitude and altitude sickness


0 / 20 complete

High Yield Notes

4 pages


Pulmonary changes at high altitude and altitude sickness

of complete

External Links


Content Reviewers

Viviana Popa, MDRishi Desai, MD, MPH

Kara Lukasiewicz, PhD, MScBMC

Will Wei


Rachel Yancey

David G. Walker

Zachary Kevorkian, MSMI

Robyn Hughes, MScBMC

Evode Iradufasha, MD

The air we breathe in has the same amount of oxygen (about 21 percent or just 0.21) at all altitudes. This is referred to as the Fraction of Inspired Oxygen or FiO2. However, the atmospheric air pressure, or Patm, decreases with altitude from about 760 mmHg at sea level to about 500 mmHg at the top of a 3000 meter mountain. So the problem is not that there’s proportionally less oxygen at high altitudes, but rather the problem is that the lower air pressure means that the same oxygen proportion will result in a lower partial pressure of oxygen in the alveoli, or PAO2 for short. So when there’s an increase in altitude, the amount of oxygen getting to the alveoli reduces. But luckily, the body makes physiological changes to keep the tissues well oxygenated even at low atmospheric pressures. Now if that fails, it can lead to altitude sickness.  

OK, so normally, the respiratory mucosa is a bit moist, and at 37 degree Celsius (a normal body temperature), some water molecules exist as water vapor. These molecules create a pressure of their own known as the vapor pressure or pH2O, which is about 47 mm Hg. So the air we breathe in mixes up with these vapors and becomes humidified.

Now, at the end of inspiration, the air pressure within the alveoli becomes equal to the Patm, or the air pressure outside the body, but the composition is a bit different due to the humidification that takes place in the respiratory tract and alveoli. So if we want to know how much of the dry air remains within the alveoli, we have to subtract this vapor pressure from the mixture and then,  multiply the dry air pressure with FiO2, to get the amount of oxygen that gets into the alveoli.

OK, now, across the alveolo-capillary membrane, gas exchange is happening all the time. Some oxygen molecules are diffusing across the membrane and binding to the hemoglobin within red blood cells. At the same time, red blood cells are dropping off carbon dioxide which diffuses from the blood, through the membrane, and into the alveoli so that it can be released in exhalation.   OK, let's check the amount of each of the gas crossing the wall. If we assume that there is no carbon dioxide in the inspired air, then that means that all of the carbon dioxide that is in the alveoli must have come from deoxygenated blood in the capillaries. The partial pressure of carbon dioxide in capillaries, or PaCO2, varies between 35 to 45 mm Hg, but let’s take the average, 40 mm Hg, and say that it’s the amount of CO2 that’s diffusing from the blood into the alveolar sacs. Now while this is happening, oxygen is also diffusing in the other direction, from the alveoli to the blood. So we have to determine the amount of oxygen that’s leaving and subtract it from the amount that’s in the alveoli. That gives us the steady state amount of oxygen partial pressure available in the alveoli, or PAO2. The amount of oxygen going into the blood, gets delivered to the body cells where it is used to oxidize substrates. Now, it turns out that there’s a pretty reliable ratio of carbon dioxide entering the alveoli to oxygen entering the blood represented by PaO2, with a little a for arteriole. This ratio is called the respiratory quotient or RQ. Rearranging a bit, that means that the amount of oxygen entering the blood is equal to the amount of carbon dioxide entering the alveoli divided by RQ.  RQ varies a bit, but for someone eating a mixed diet, RQ is about 0.8. So, if the amount of carbon dioxide entering the alveoli is 40 mm hg, the amount of oxygen that’s being exchanged would be PaCO2/RQ, or 40 mm hg/0.8 or 50 mm Hg.  To tie things up, the partial pressure of oxygen available in alveoli at the end of every inspiration is the partial pressure of oxygen in the inspired dry air, minus the partial pressure of oxygen that has already left the alveoli to the capillaries. That’s the alveolar gas equation.


At high altitudes, the air pressure decreases and as a result the pressure driving oxygen through alveoli and into circulation also decreases. As a result, people can become hypoxic which causes many problems including increased pulmonary vascular resistance.

As people spend much time at high altitudes, the body adapts and produces 2,3-bisphosphoglyceric acid, which helps decrease hemoglobin’s affinity for oxygen, allowing more oxygen delivery to oxygen-deprived tissues. The kidneys also increase the release of erythropoietin to stimulate the bone marrow to produce more red blood cells.

When people ascend to high altitudes too quickly, the body hasn't got time to adapt to low air pressures, and this can result in altitude sickness. Symptoms include headache, fatigue, shortness of breath, nausea, and loss of appetite. In severe cases, it can lead to high-altitude cerebral edema (HACE) or high-altitude pulmonary edema (HAPE), both of which are life-threatening conditions.


Copyright © 2023 Elsevier, except certain content provided by third parties

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.